Personalized approaches are crucial for achieving success and thriving in today's fast-paced, competitive landscape. Our tailored services in life sciences and healthcare market research and consulting offer customized research solutions, meticulous data handling and analysis, and comprehensive insights tailored to our industry partners' specific needs. From evaluating opportunities and assessing priorities to gathering competitive intelligence, performing health economics and outcomes research (HEOR), providing conference coverage, understanding consumer insights, strategizing market entry plans, offering decision-making support, or conducting investment opportunity analysis in both established markets and emerging ones – we have got you covered.
In life sciences and healthcare, SGA's dedicated team specializes in research execution and monitoring, administrative and medical records, insurance records, vital records, follow-up, medical records, and peer-reviewed literature. These comprehensive data services serve global service providers and are presented in easily configurable, user-friendly dashboards and regular reports available daily, weekly, or monthly.
Elevate your pharmaceutical and medtech endeavours with our specialized CRO services, focusing on biostatistics, clinical trial data management, medical writing, and clinical trial project management. Our dedicated team ensures the seamless execution of clinical trials, adhering to rigorous standards and accelerating the path to regulatory approval.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English U.S. & U.K. experts either in-house or partnerships.
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with the in-house capabilities of primary market research, financial research, data analytics, data engineering, IT, and ESG research and consulting, helps to present credible competitive information.
Whitepapers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
Whitepapers
Future Trends and Technological Advances in Vaccine and...
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
Whitepapers
Market Entry in 2023: Why Must You Also Look at Markets...
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
CASE STUDIES
Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labeled research coverage.